The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species
ABSTRACT In recent decades, there has been an increase in the occurrence of fungal infections; yet, the arsenal of drugs available to fight invasive infections remains very limited. The development of new antifungal agents is hindered by the restricted number of molecular targets that can be exploit...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2024-11-01
|
| Edice: | mBio |
| Témata: | |
| On-line přístup: | https://journals.asm.org/doi/10.1128/mbio.02502-24 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|